544 Rectal Indomethacin Significantly Decreases the Rate of Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Given Before the Procedure: A Personalized Medicine Approach Using Meta-Analysis of Aggregate Subgroup Data From Randomized-Controlled Trials

Journal article

Peer reviewed

Mohammad Yaghoobi, Mohammed A. Alzahrani, Julia McNabb-Baltar, Myriam Martel and Alan N. Barkun

Gastrointestinal endoscopy, Vol.85(5), pp.AB80-AB80

01/05/2017

Metrics

1 Record Views

Title: 544 Rectal Indomethacin Significantly Decreases the Rate of Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Given Before the Procedure: A Personalized Medicine Approach Using Meta-Analysis of Aggregate Subgroup Data From Randomized-Controlled Trials
Creators - without role: Mohammad Yaghoobi - McMaster University
Mohammed A. Alzahrani - McMaster University
Julia McNabb-Baltar - Brigham and Women's Hospital
Myriam Martel - McGill University Health Centre
Alan N. Barkun - McGill University Health Centre
Publication Details: Gastrointestinal endoscopy, Vol.85(5), pp.AB80-AB80
Publisher: Elsevier Inc
Identifiers: 9912143808331
Academic Unit: Al Baha University
Language: English
Resource Type: Journal article